On Sunday, President Trump posted to Truth Social that he planned on implementing a most-favored-nation policy for ...

The Avmapki Fakzynja Co-Pack marks the first FDA-approved treatment for adult patients with KRAS-mutated recurrent low-grade ...

Beyond technology, regulations weigh heavily on the minds of pharma executives. Four out of 10 leaders believe regulatory ...

While expressing a desire for revenue growth is common, understanding the “why” behind that intention is crucial. Delving ...

Lilly announced several changes to its executive leadership team. 1 These changes are mostly related to the company’s ...

Interim results from the ongoing Phase III ASSURE trial demonstrated that Livdelzi maintained a consistent biochemical ...

The use of RWD data in place of placebo groups is improving various elements across the clinical trial space.

Will Pih, co-founder, Two Labs, explains how ongoing regulatory uncertainty is slowing clinical trial activity and hiring ...

In an effort to combat the state’s shortage of primary care physicians, Blue Cross Blue Shield of Massachusetts is offering ...

Chip Parkinson, CEO, GiftHealth, explains how AI-powered data integration is bringing new hope to patients by revealing ...

With this is mind, Abbott announced a new program that combines one of the most popular sports in the world with education ...

Fran Gregory, VP, emerging therapies, Cardinal Health, emphasizes the need for long-term outcomes tracking and robust health ...